APRIL and TALL-I and receptor BCMA and TACI: System for regulating humoral immunity

Nature Immunology

Volumn 1, Issue 3, 2000, Pages 252-256

  Yu, Gang ^a   Boone, Tom ^a   Delaney, John ^a   Hawkins, Nessa ^a   Kelley, Michael ^a   Ramakrishnan, Meena ^a   McCabe, Susan ^a   Qiu, Wan Rong ^a   Kornuc, Masayo ^a   Xia, Xing Zhong ^a   Guo, Jane ^a   Stolina, Marina ^a   Boyle, Willim J ^a   Sarosi, Ildiko ^a   Hsu, Hailing ^a   Senaldi, Giorgio ^a   Theill, Lars E ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANP32B PROTEIN, HUMAN; ANTIGEN; B CELL ACTIVATING FACTOR; B CELL MATURATION ANTIGEN; HEMOCYANIN; HYBRID PROTEIN; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE-LIMPET HEMOCYANIN; MEMBRANE PROTEIN; NEUROPEPTIDE; NUCLEAR PROTEIN; TNFRSF13B PROTEIN, HUMAN; TNFRSF13B PROTEIN, MOUSE; TNFRSF17 PROTEIN, HUMAN; TNFRSF17 PROTEIN, MOUSE; TNFSF13B PROTEIN, HUMAN; TNFSF13B PROTEIN, MOUSE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BINDING COMPETITION; C57BL MOUSE; CELL COUNT; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; FEMALE; HISTOLOGY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; ORGAN SIZE; PHYSIOLOGY; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; B-CELL ACTIVATING FACTOR; B-CELL MATURATION ANTIGEN; B-LYMPHOCYTES; BINDING, COMPETITIVE; CELL COUNT; FEMALE; HEMOCYANIN; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; NUCLEAR PROTEINS; ORGAN SIZE; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SPLEEN; T-LYMPHOCYTES; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 5944227779     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/79802     Document Type: Article

References (28)

1. Hahne, M. et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med 188, 1185-1190 (1998).
2. Anderson, D. M. et al. A homolog of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179 (1997).
3. Chinnaiyan, A. M. et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992 (1996).
4. Chicheportiche, Y. et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272, 32401-32410 (1997).
5. Khare, S. D. et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 97, 3370-3375 (2000).
6. Moore, P.A. et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263 (1999).
7. Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319 (1997)
8. Frade, J. M., Rodriguez, T.A. & Barde, Y.A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166-168 (1996).
9. Smith, C.A., Farrah, T. & Goodwin, R.G. The TNF receptor superfamily of cellular and viral protein: activation, costimulation, and death. Cell 76, 959-962 (1994).
10. Screaton, G. & Xu, X. T cell life and death signalling via TNF-receptor family members. Curr. Opin. Immunol. 12, 316-322 (2000).
11. Kelly, K., Manos, E., Jensen, G., Nadauld, L .& Jones D.A. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 60, 1021-1027 (2000).
12. Bucher, P., Karplus, K., Moeri, N & Hofmann, K.A flexible motif search technique based on generalized profiles. Comput. Chem. 20, 3-23 (1996).
13. Shu, H. B., Hu, W. H. & Johnson, H. TALL-1 is a novel member of the TNF family that is down-regufated by mitogens. J. Leukoc. Biol. 65, 680-683 ( 1999).
14. von Bulow, G. U. & Bram, R.J. NF-AT activation induced by a CAML-eracting member of the tumor necrosis factor receptor superfamily. Science 278, 138-141 (1997).
15. Laabi, Y., Gras, M., Brouet, J. C., Berger, R., Larsen, C.J. & Tsapis, A. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res. 22, 1147-1154 (1994).
16. Madry, C. et al. The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. Int. Immunol. 10, 1693-1702 (1998).
17. Schneider, P. et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747-1756 (1999).
18. Xia, X. Z., et al. TACI is a TRAF-interacting receptor for TALL-1, a Tumor Necrosis Factor family member involved in B cell regulation. J. Exp. Med. 192, 137-143 (2000).
19. Gross, J. A. et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999 (2000).
20. Sheridan, J. P. et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818-821 (1997).
21. Lamam, J. D. & Claassen, E. T-Cell-Independent and T-Cell-Dependent Humorol Immunity (ed. CM, S.) (John Wiley & Sons, New York, 1996).
22. Dubois, B. et al. Dendritic Cells Enhance Growth and Differentiation of CD40-activated B Lymphocytes. J. Exp. Med. 185, 941-951 (1997).
23. Kooten, C. & Banchereau, J. CD40-CD40 ligand. J. Leukoc. Bio. 67, 2-17. (2000).
24. Armitage, R. J. & Alderson, M. R. B-cell stimulation. Curr. Opin. Immunol. 7, 243-247. (1995).
25. Shanebeck, K. D. et al. Regulation of murine B cell growth and differentiation by CD30 ligand. Eur. J. Immunol. 25, 2147-2153 (1995).
26. Marsters, S.A. et al. Interaction of the TNF homologues BlyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10, 785-788 (2000).
27. Nakayama, K. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327, 625-635 (1997).
28. Hatzoglou, A. et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165, 1322-1330 (2000).